Drug Profile
Research programme: G protein-coupled receptor modulators - Astellas Pharma/TaiGen Biotechnology
Alternative Names: GPCR modulators - Astellas/TaiGenLatest Information Update: 01 Jun 2010
Price :
$50
*
At a glance
- Originator Astellas Pharma; TaiGen Biotechnology
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunological disorders; Inflammation
Most Recent Events
- 01 Jun 2010 Development discontinued for Immunological disorders before 2010
- 11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma
- 28 Mar 2003 Preclinical trials in Immunological disorders in Japan (unspecified route)